"Philips Halts US Sales of Sleep Apnea Machines After FDA Links 561 Deaths to Recalled Devices"
TL;DR
The FDA has linked 561 deaths to the recalled Philips Respironics breathing assistance devices due to the breakdown of polyester-based polyurethane foam used in the machines, leading to health injuries. More than 116,000 reports, including the 561 deaths, have been associated with the foam breakdown. Philips has stopped selling breathing machines in the U.S. until it meets conditions laid out in its settlement with the FDA, which could take at least a year, and has agreed to pay nearly $480 million to affected users while facing numerous lawsuits.
Topics:businesshealth-safety#fda#health-safety#medical-devices#philips-respironics#recall#sleep-apnea
- 561 deaths linked to recalled Philips sleep apnea machines, FDA says Scripps News
- Philips Suspends Sales of CPAP and Other Breathing Devices After Recall The New York Times
- Philips announces its 2023 Fourth-Quarter and Annual Results Philips
- Philips stops selling sleep apnea machines in US following mass recalls The Verge
- FDA says 561 deaths tied to recalled Philips sleep apnea machines Yahoo Finance
Want the full story? Read the original reporting
Read on Scripps News